Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Cash from Investing Activities (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Cash from Investing Activities for 8 consecutive years, with $4.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Investing Activities rose 9422.92% to $4.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.9 million, a 3889.61% increase, with the full-year FY2024 number at -$490000.0, down 2433.33% from a year prior.
  • Cash from Investing Activities was $4.5 million for Q3 2025 at SANUWAVE Health, up from -$1.2 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $4.5 million in Q3 2025 to a low of -$1.2 million in Q2 2025.
  • A 3-year average of $244090.9 and a median of -$92000.0 in 2024 define the central range for Cash from Investing Activities.
  • Biggest YoY gain for Cash from Investing Activities was 9422.92% in 2025; the steepest drop was 1159.78% in 2025.
  • SANUWAVE Health's Cash from Investing Activities stood at $177000.0 in 2023, then crashed by 233.33% to -$236000.0 in 2024, then skyrocketed by 1996.19% to $4.5 million in 2025.
  • Per Business Quant, the three most recent readings for SNWV's Cash from Investing Activities are $4.5 million (Q3 2025), -$1.2 million (Q2 2025), and -$162000.0 (Q1 2025).